Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 7—July 2023
Research

Highly Pathogenic Avian Influenza Virus (H5N1) Clade 2.3.4.4b Introduced by Wild Birds, China, 2021

On This Page
Materials and Methods
Results
Discussion
Cite This Article
Figures
Figure 1
Figure 2
Figure 3
Tables
Table
Downloads
Article
Appendix 1
Appendix 2
RIS [TXT - 2 KB]
Article Metrics
Metric Details
Related Articles
Influenza A(H5N1) Virus in Traveler
Evidence of H5N1 Influenza Spillover Infections in Horses, Mongolia
Review of AIV Infection during Pregnancy
More articles on Influenza
Author affiliations: State Key Laboratory for Animal Didease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China (J. Tian, X. Bai, M. Li, X. Zeng, X. Song, Z. Zhao, G. Tian, L. Liu, Y. Guan, Y Li, H. Chen); Preventive and Control Center for Animal Disease of Heilongjiang Province, Harbin (J. Xu, P. Li, M. Wang)

Cite This Article

Abstract

Highly pathogenic avian influenza (HPAI) subtype H5N1 clade 2.3.4.4b virus has spread globally, causing unprecedented large-scale avian influenza outbreaks since 2020. In 2021, we isolated 17 highly pathogenic avian influenza H5N1 viruses from wild birds in China. To determine virus origin, we genetically analyzed 1,529 clade 2.3.4.4b H5N1 viruses reported globally since October 2020 and found that they formed 35 genotypes. The 17 viruses belonged to genotypes G07, which originated from eastern Asia, and G10, which originated from Russia. The viruses were moderately pathogenic in mice but were highly lethal in ducks. The viruses were in the same antigenic cluster as the current vaccine strain (H5-Re14) used in China. In chickens, the H5/H7 trivalent vaccine provided complete protection against clade 2.3.4.4b H5N1 virus challenge. Our data indicate that vaccination is an effective strategy for preventing and controlling the globally prevalent clade 2.3.4.4b H5N1 virus.

The hemagglutinin (HA) gene of highly pathogenic avian influenza subtype H5 viruses has evolved into multiple clades (clades 0–9), and some clades are further divided into subclades. Of the 2 dominant clades, 2.3.2.1 has been further categorized into 7 (2.3.2.1a–g) and 2.3.4.4 have been further categorized into 8 (2.3.4.4a–h) subclades (1–3). The World Organisation for Animal Health reported that >8,000 outbreaks of highly pathogenic avian influenza (HPAI) subtype H5N1 clade 2.3.4.4b occurred in birds during October 2020–October 2022. Massive numbers of birds across 4 continents (Europe, Asia, Africa, and North America) were humanely killed directly or indirectly by infection with clade 2.3.4.4b H5 HPAI viruses (4).

H5 HPAI viruses of several clades have spread intercontinentally through global migration of wild birds. In 2005, clade 2.2 H5N1 virus spread by wild birds caused numerous outbreaks in wild birds and domestic poultry in countries throughout Asia, the Middle East, Europe, and West Africa (5,6). In 2009, clade 2.3.2 H5N1 virus caused problems mainly in Asia and eastern Europe (7,8). In 2014, both clade 2.3.4.4b H5N8 and clade 2.3.2.1c H5N1 viruses spread and circulated in Eurasia, the Middle East, and Africa (9–11). At the beginning of 2014, a clade 2.3.4.4c H5N8 virus emerged in South Korea and then circulated in Eurasia and Africa. In 2015, that same virus spread to North America and reassorted with local low pathogenicity avian influenza (LPAI) viruses to produce subtype H5N2, which circulated in the United States during 2015–2016 (12,13). At the beginning of 2020, clade 2.3.4.4b H5N8 virus caused disease outbreaks and destroyed poultry across Europe, after which it spread to many countries in Asia (14,15). The H5N8 virus reassorted with different viruses and formed several other subtypes of H5 viruses (e.g., H5N1, H5N2, H5N3, H5N4, H5N5, and H5N6) in different countries and regions. Among them, H5N1 became the globally predominant variant (16,17). In late 2021, the virus was carried across the Atlantic Ocean to North America (18). The viruses caused huge ongoing outbreaks in Europe and North America and led to massive destruction of poultry and wild bird populations (4,19,20).

Clade 2.3.4.4b H5 viruses have crossed the bird–mammal barrier to infect humans and other mammals. Since the beginning of 2020, human infection with influenza A(H5N1) clade 2.3.4.4b viruses has been detected in Spain, the United Kingdom of Great Britain and Northern Ireland, the United States, China, and Vietnam and reported to the World Health Organization (21). Seven human infections caused by influenza A(H5N8) virus were reported in the Russian Federation (22), and some infections caused by H5N6 virus were reported in China in those 3 years (2020–2022) (23). In addition, fatal 2.3.4.4b H5N1 infection of some carnivorous mammals (e.g., foxes, otters, red foxes, skunks, coyotes, bobcats) and marine mammals (e.g., harbor seals, dolphins) has been reported in Europe and North America (24).

Clade 2.3.4.4b H5N1 virus has become a new threat to the global poultry industry and to public health. To learn more about its spatial transmission and biological properties, we performed extensive phylogeographic and epidemiologic analyses of the globally circulating H5N1 viruses detected during 2020–2022, evaluated the pathogenicity of H5N1 from China in mammalian and waterfowl hosts, compared H5N1 antigenicity with that of the updated vaccine candidate, and assessed the protective efficacy of the current H5-Re14 vaccine against challenge with H5N1 isolates.

All studies with live viruses were conducted in a Biosafety Level 3 laboratory approved for such use by the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences. All experiments using animals were conducted in strict accordance with recommendations in the Guide for the Care and Use of Laboratory Animals of the Ministry of Science and Technology of the People’s Republic of China. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences (approval nos.: duck, 211015-01; mouse, 211231-02; chicken, 211112-01).

 

Materials and Methods

Sample Collection and Virus Isolation

During 2020–2021, we collected 7,421 fresh fecal samples, 507 swab samples, and 6 tissue samples from wild birds in accordance with the regular surveillance of wild birds in China (Table). The samples were amplified in specific-pathogen–free (SPF) chicken embryos, and the HA subtype was identified by using the hemagglutinin inhibition (HI) test with a panel of H1–H16 reference serum. We verified the neuraminidase (NA) subtype by using reverse transcription PCR analysis with a panel of N1–N9 subtype primers (reference serum and primer sequences available on request). We identified host species by using DNA barcoding with the cytochrome C oxidase I mitochondrial gene (25).

Genome Sequencing and Phylogenic and Phylodynamic Analyses

We extracted total influenza A virus RNA from the allantoic fluid of virus-infected chicken embryos by using the QIAmp Viral RNA Mini Kit (QIAGEN, https://www.qiagen.com). We performed reverse transcription PCR by using a panel of gene-specific primers and sequenced the products by using an Applied Biosystems DNA analyzer (primers available on request). The genetic information collected from January 1, 2020, to October 17, 2022, was downloaded from GISAID (https://www.gisaid.org) on October 17, 2022 (Appendix 1). We aligned sequences by using MAFFT version 7.475 with default settings (26) and ran neighbor-joining trees by using MEGA version 11 for 1,000 ultrafast bootstraps (27). To categorize the groups of each segment in the phylogenetic trees, we used a sequence identity cutoff of >95%. We constructed a maximum-clade credibility time-scaled phylogenetic tree of HA sequences from clade 2.3.4.4b H5N1 viruses by using the SRD06 nucleotide substitution model and an uncorrelated lognormal relaxed clock model (28). To investigate the transmission patterns of the clade 2.3.4.4b H5N1 viruses, we performed a phylogeographic analysis by using an asymmetric model with Bayesian stochastic search variable selection implemented in BEAST version 1.10.4 (28,29). We grouped the sequences from 1,529 isolates into 11 distinct geographic categories (Appendix 2 Table 3). To summarize the diffusion rates, we used the Bayesian stochastic search variable selection, and to estimate Bayes factors, we used SpreaD3 version 0.9.6 (https://rega.kuleuven.be/cev/ecv/software/SpreaD3) (Appendix 2 Table 4).

Animal Studies

We selected 2 representative isolates, A/mandarin duck/Heilongjiang/HL-1/2021 (MD/HLJ/HL-1/2021) and A/whooper swan/Henan/14/2021 (WS/HeN/14/2021), to test in mice and ducks. The 50% lethal dose (LD50) for mice was tested in groups of five 6-week-old female BALB/c mice (Vital River, https://www.vitalriver.com). The mice were intranasally inoculated with a 101.0 to 106.0 50% egg infectious dose (EID50) of virus in a volume of 50 µL and then monitored daily for weight loss and death for 14 days. LD50 values for mice were calculated according to the Reed-Muench method (30). To evaluate virus replication, we tested 3 more mice in the 106.0 EID50 group and humanely killed them on postinoculation day 3 to assess virus titers in their nasal turbinates, lungs, brains, kidneys, and spleens.

Among the ducks, we inoculated groups of eight 3-week-old SPF ducks (Jinding duck, a local breed; National Poultry Laboratory Animal Resource Center, Harbin, China) intranasally with 106.0 EID50 of H5N1 virus in a volume of 0.1 mL; at 24 h after inoculation, 3 contact ducks were put in the same cage. On postinoculation day 3, we randomly selected 3 of 8 infected ducks, humanely killed them, and collected their organs (brain, spleen, kidneys, pancreas, cecal tonsil, bursa of Fabricius, thymus, lungs, and larynx) for virus titration. We observed the remaining 5 infected ducks and 3 contact ducks for 2 weeks and collected oropharyngeal and cloacal swab samples on postinoculation days 3 and 5 to detect virus shedding.

Antigenic Analysis

We used HI to perform antigenic analysis (31). We generated chicken antiserum of H5 vaccine seed viruses (H5-Re11, H5-Re12, H5-Re13, and H5-Re14) (Appendix 2 Table 7) by inoculating 5-week-old SPF chickens with 0.3 mL of the oil-emulsified inactivated viruses (32).

Challenge Study of Clade 2.3.4.4b H5N1 Virus in Chickens

We vaccinated groups of ten 3-week-old white leghorn SPF chickens (National Poultry Laboratory Animal Resource Center) with a 0.3-mL intramuscular injection of the trivalent H5/H7 vaccine previously reported by Zeng et al. (32,33) (Harbin Weike Biotechnology Co., http://www.hvriwk.com) or with phosphate-buffered saline as a control. Three weeks after vaccination, we challenged the chickens intranasally with 105 EID50 of MD/HLJ/HL-1/2021 in a volume of 0.1 mL. We collected oropharyngeal and cloacal swab samples on postchallenge days 3 and 5 to detect the virus and observed birds for disease and death for 2 weeks after challenge.

Results

Clade 2.3.4.4b H5N1 Virus Detection

As part of regular surveillance of wild birds during 2020–2021, we collected 7,934 samples, from which we detected 17 H5N1 HPAI viruses and 20 LPAI viruses of multiple subtypes (Table). To determine the evolution of the H5N1 viruses, we sequenced the whole genomes of the 17 HPAI viruses, deposited the sequences in the GISAID database (accession nos. EPI2070071–0206), and performed phylogenic analysis of these viruses together with global clade 2.3.4.4b HPAI H5 viruses submitted to GISAID from January 1, 2020, to October 17, 2022.

The HA genes of the 17 H5N1 viruses shared 98.3%–100% identity at the nucleotide level, and the NA genes shared 97.45%–100% identity (Appendix 2 Figure 2, Figure 3, panel A). The HA genes of the clade 2.3.4.4b H5 strains formed 2 branches—East Asia and Eurasia/Africa—in the phylogenetic tree (Appendix 2 Figures 1, 2); 2 H5N1 viruses isolated in Heilongjiang Province in this study belonged to the East Asia branch, whereas the other 15 viruses belonged to the Eurasia/Africa branch. The NA genes of the 17 viruses all belonged to the group Europe H5N1 2020 (Appendix 2 Figure 3, panel A). Identity at the nucleotide level was 94.12%–100% for the polymerase basic (PB) 2 genes, 92.96%–100% for the PB1 genes, 97.3%–100% for the polymerase acidic (PA) genes, 97.6%–100% for the nucleoprotein (NP) genes, 98.7%–100% for the matrix (M) genes, and 95.65%–100% for the nonstructural protein (NS) genes of the 17 H5N1 viruses, and they formed multiple groups in their phylogenetic trees (Appendix 2 Figure 3). Diversity of the internal genes of clade 2.3.4.4b H5N1 viruses was greater than that of the HA and NA genes. Of note, the 8 genes of the MD/HLJ/HL-1/2021 and MD/HLJ/HL-2/2021 viruses were similar, and the 8 genes of the other 15 viruses were similar, indicating that these 17 viruses formed 2 different genotypes.

Complex Reassortment of the H5N1 Wild Bird Viruses

Figure 1

Formation of 2 representatives of avian influenza (H5N1) virus from China. Viral particles are represented by colored ovals containing horizontal bars representing the 8 gene segments (from top to bottom: PB2, PB1, PA, HA, NP, NA, M, and NS). Gene segments of the reassortants are colored according to their corresponding source virus. HA, hemagglutinin; LPAIV, low pathogenicity avian influenza virus; M, matrix; NA, neuraminidase; NP, nucleoprotein; NS, nonstructural protein; PA, polymerase acidic; PB, polymerase basic.

Figure 1. Formation of 2 representatives of avian influenza (H5N1) virus from China. Viral particles are represented by colored ovals containing horizontal bars representing the 8 gene segments (from top to bottom:...

To investigate the formation of the 17 H5N1 HPAI viruses, we used MD/HLJ/HL-1/2021 and WS/HeN/14/2021 as representatives of the 2 branches and conducted BLAST analysis (https://platform.epicov.org/epi3/frontend#27b74d) of the highest homology viruses to the 8 segments of 2 reference viruses from GISAID. The data showed that both representatives were reassortants (Figure 1; Appendix 2 Table 2). Seven genes of WS/HeN/14/2021 (PB1, HA, NA, PA, NP, M, and NS) were closely related to those of the H5N1 HPAI viruses in Europe during 2020–2021; the PB2 gene of WS/HeN/14/2021 was provided by the H5N8 HPAI virus in Russia in 2020. MD/HLJ/HL-1/2021 had 5 genes (HA, NA, PA, NP, and M) closely related to those of the H5N1 HPAI viruses in Europe during 2020–2021; its PB1 gene was closely related to the H5N8 HPAI virus in Russia during 2020, whereas its PB2 and NS genes were from the LPAI viruses that circulated in Russia during 2020. Our analysis thus demonstrates that clade 2.3.4.4b H5N1 viruses have undergone complex reassortment with LPAI viruses in different geographic sites since 2020.

Genotypic Analysis and Spread of Clade 2.3.4.4b H5N1 Viruses

Cui et al. analyzed 233 strains of clade 2.3.4.4b H5N1 viruses that were detected globally from October 1, 2020, to April 1, 2022, and revealed 16 genotypes (G01–16) (17). The 2 H5N1 viruses from Heilongjiang in this study belonged to G07, whereas the other 15 H5N1 viruses belonged to G10 (Appendix 2 Figure 1). Within 2 months of their detection in wild birds, viruses of these 2 genotypes spread to and were detected in domestic waterfowl in China (17).

Because the viruses are still spreading globally, we sought to gain further insight into the large-scale cross-continental transmission and reassortment patterns of clade 2.3.4.4b H5N1 viruses. To that end, we analyzed the sequences of 1,296 viruses that became available from April to October 2022 and detected an additional 19 genotypes (Appendix 1; Appendix 2 Table 3, Figure 4), including 5 in western Europe (G21, G28, G33, G34, and G35), 2 in eastern and central Europe (G19 and G20), 1 in Russia (G17), 1 in Africa (G18), and 10 in North America (G22, G23, G24, G25, G26, G27, G29, G30, G31, and G32) (Appendix 2 Table 3, Figure 5). We further grouped the available isolates into 11 distinct geographic regions, performed a phylogeographic analysis of their HA genes (Appendix 2 Table 3, Figure 5), and identified 22 spread pathways of clade 2.3.4.4b H5N1 viruses. Of note, 4 of those pathways were decisively supported with Bayes factors >1,000: 2 pathways showed G01 spreading from eastern and central Europe to Russia and from western Europe to North America; 1 showed G04 spreading from western Europe to southern Europe; and the fourth showed G07 spreading from eastern Asia to China (Appendix 2 Table 4). Those data indicate that Europe was the epidemic source for the global spread of clade 2.3.4.4b H5N1 viruses.

Amino Acid Residues of Clade 2.3.4.4b H5N1 Viruses

All 17 H5N1 viruses had residues 137A and 192I and did not have the glycosylation site at positions 158–160 in their HA (H3 numbering) (Appendix 2 Table 5), which have been reported to increase the affinity of avian influenza viruses for human-type receptors (34,35). The viruses also carried critical virulence-increasing residues, including 66S in PB1-F2 in 15 viruses; 30D, 43M, and 215A in M1 and 42S, 103F, and 106M in NS1 of all 17 viruses (36–41) (Appendix 2 Table 5). Therefore, clade 2.3.4.4b H5N1 viruses may have the capacity to infect and be virulent in humans.

Virulence of H5N1 Wild Bird Viruses in Mice

Figure 2

Replication and virulence of representative highly pathogenic avian influenza virus (H5N1) viruses in mice and ducks. A) Virus titers in organs of mice that were humanely killed on postinfection day 3 with 106 EID50 of the test viruses. B, C) MLD50 of the indicated viruses. D) Virus titers in organs of ducks that were killed on day 3 post inoculation with 106 EID50 in 0.1 mL of the indicated viruses. E) Virus shedding from ducks on the indicated days after inoculation. F) Death pattern of ducks in the infected and control groups. EID50, 50% egg infectious dose; MLD50, 50% lethal dose for mice.

Figure 2. Replication and virulence of representative highly pathogenic avian influenza virus (H5N1) viruses in mice and ducks. A) Virus titers in organs of mice that were humanely killed on postinfection day...

In several countries, clade 2.3.4.4 H5 viruses have caused infections in humans and other mammals, including terrestrial small carnivores and marine mammals (Appendix 1). To evaluate the replication and virulence of wild bird H5N1 viruses in mammals, we tested 2 representative strains in BALB/c mice: MD/HLJ/HL-1/2021 in G07 and WS/HeN/14/2021 in G10. We found that both viruses replicated systemically and were detected in the nasal turbinates, lungs, spleens, and kidneys of the mice; MD/HLJ/HL-1/2021 was also detected in the brains of the mice (Figure 2, panel A). The LD50 value of MD/HLJ/HL-1/2021 in mice was 4.38 log10 EID50 and of WS/HeN/14/2021 was 5.17 log10 EID50 (Figure 2, panels B, C), indicating that H5N1 wild bird viruses are moderately pathogenic in mice (1,5,7,9).

Lethality of H5N1 Wild Bird Viruses in Ducks

Many H5 viruses that are highly pathogenic to galliformes (e.g., chickens, quail, and turkeys) may still be of low pathogenicity to waterfowl (1,15). To investigate the replication and virulence of clade 2.3.4.4b H5N1 virus in waterfowl, we tested MD/HLJ/HL-1/2021 and WS/HeN/14/2021 in SPF ducks. We found that the 2 viruses replicated efficiently in ducks and were detected in all 9 investigated organs of ducks that were humanely killed on postinoculation day 3 (Figure 2, panel D). We detected virus shedding in oropharyngeal and cloacal swab samples from the infected ducks and contact ducks on postinoculation days 3 and 5 (Figure 2, panel E). MD/HLJ/HL-1/2021 led to the death of 4 of 5 inoculated and 3 contact ducks, whereas WS/HeN/14/2021 led to the death of all 5 inoculated and 3 contact ducks (Figure 2, panel F). Those data indicate that the 2 clade 2.3.4.4b H5N1 viruses we isolated from wild birds are lethal to ducks.

Antigenic Matching of the H5 Vaccine Seed Virus Re14 with the H5N1 Wild Bird Viruses

Figure 3

Antigenic difference of avian influenza (H5N1) virus isolates with H5 vaccine strains and protective efficacy of H5 vaccine against the challenge of H5N1 virus. A) Antigenic cartography of H5N1 viruses. The map was generated by using Antigenic Cartography software (https://acmacs-web.antigenic-cartography.org); 1 unit (grid) represents a 2-fold change in the HI assay results (Appendix 2 Table 7). B) HI antibody titers of vaccinated chickens against the vaccine seed virus and the challenge strain. C) Virus shedding from chickens on postchallenge days 3 and 5. D) Survival patterns of chickens in the vaccinated and control groups after challenge with the indicated H5N1 virus. EID50, 50% egg infectious dose; HI, hemagglutination inhibition.

Figure 3. Antigenic difference of avian influenza (H5N1) virus isolates with H5 vaccine strains and protective efficacy of H5 vaccine against the challenge of H5N1 virus. A) Antigenic cartography of H5N1 viruses....

To evaluate the antigenic difference between the emerged clade 2.3.4.4b of H5N1 viruses and the H5 vaccine strains, we generated antiserum in SPF chickens against 4 H5 vaccine strains (H5-Re11 [clade 2.3.4.4h], H5-Re12 [clade 2.3.2.1f], H5-Re13 [clade 2.3.4.4h], and H5-Re14 [clade 2.3.4.4b]) and tested their cross-reactive HI antibody titers to 4 representative viruses detected in this study: A/mandarin duck/Heilongjiang/HL-1/2021, A/whooper swan/Shanxi/608/2021, A/whooper swan/Henan/14/2021, and A/mandarin duck/Henan/426/2021 (Appendix 2 Table 7). We found that the 4 viruses reacted well with the antiserum of H5-Re14, with titers ranging from 64 to 128, less than 4-fold to the homologous titer, but reacted poorly with the antiserum of the other 3 vaccine strains (Figure 3, panel A; Appendix 2 Table 7).

We further evaluated the protective efficacy of the H5/H7 trivalent vaccine in chickens against challenge with a clade 2.3.4.4b H5N1 virus. Three weeks after vaccination, high titers of HI antibody to vaccine strain H5-Re14 and the H5N1 wild bird virus MD/HLJ/HL-1/2021 developed in the chickens (Figure 3, panel B). The vaccinated chickens were completely protected against MD/HLJ/HL-1/2021, with no virus shedding, and all chickens survived during the 14-day observation period (Figure 3, panels C, D); however, all control chickens died within 4 days of challenge, and the 7 chickens that were alive on postchallenge day 3 shed high titers of virus (Figure 3, panels C, D). Those data indicate that the vaccine currently used in China could provide solid protection against the clade 2.3.4.4b H5N1 viruses.

Discussion

Clade 2.3.4.4b H5N8 virus caused massive outbreaks in poultry and wild birds in Europe, Africa, and Asia from January 2020 to October 2021 (15,17). During that time, the virus reassorted in countries or regions with different viruses and generated H5N1, H5N2, H5N3, H5N4, H5N5, and H5N6 viruses bearing the clade 2.3.4.4b HA gene (4,14,16,17,23). Among those new subtypes, only H5N1 viruses were widely spread by the movement of migratory birds and have caused thousands of outbreaks in Europe, Africa, Asia, and North America since their generation in the Netherlands in October 2020 (4,14,17). Our study revealed that the widely circulating H5N1 viruses have undergone complex reassortment with other LPAI viruses and formed >35 genotypes. Of those novel genotypes of H5N1 viruses, 10 were generated in North America since December 2021, when clade 2.3.4.4b H5N1 virus was first introduced to that region from western Europe (18). Given that the H5N1 reassortants found in Europe and North America have infected multiple wild mammals, their threat to public health should be carefully monitored and assessed.

Many countries in Europe and North America control HPAI by culling infected and suspected domestic birds, whereas China controls HPAI by using a massive vaccination strategy. The key to the success of the vaccination strategy is timely updates of vaccine strains (15,32,33). The currently used H5/H7 trivalent inactivated vaccine was updated and has been applied since January 2022; it is produced with 3 seed viruses: H5-Re13, targeting clade 2.3.4.4h H5 viruses; H5-Re14, targeting clade 2.3.4.4b H5 viruses; and H7-Re4, targeting H7N9 viruses (33). The antigenic assay in our study demonstrated that the H5-Re14 seed virus antigenically matches well with the recently emerged H5N1 wild bird viruses in China. The vaccine protective efficacy test also demonstrated that the novel H5/H7 trivalent vaccine provides solid protection against challenge with an emerging H5N1 isolate. The success of the mandatory vaccination policy for preventing and controlling HPAI virus in China is an example of a high-risk country using a vaccine to protect the poultry industry and of how vaccinating poultry can prevent and eliminate human infections with avian influenza virus, as evidenced by the successful control of H7N9 influenza (32,33,42). Therefore, we strongly recommend the use of vaccines to protect poultry from globally circulating 2.3.4.4b H5N1 viruses.

Dr. Tian works at the Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China, with a research focus on avian influenza virus surveillance.

Top

Acknowledgments

We thank the authors and laboratories who submitted sequences to the GISAID EpiFlu database.

This work was supported by the National Key Research and Development Program of China (grant no. 2021YFD1800200) and the earmarked fund for CARS-41.

Top

References

  1. Cui  Y, Li  Y, Li  M, Zhao  L, Wang  D, Tian  J, et al. Evolution and extensive reassortment of H5 influenza viruses isolated from wild birds in China over the past decade. Emerg Microbes Infect. 2020;9:1793–803. DOIPubMedGoogle Scholar
  2. Li  Y, Li  M, Li  Y, Tian  J, Bai  X, Yang  C, et al. Outbreaks of highly pathogenic avian influenza (H5N6) virus subclade 2.3.4.4h in swans, Xinjiang, western China, 2020. Emerg Infect Dis. 2020;26:2956–60. DOIPubMedGoogle Scholar
  3. World Health Organization/World Organisation of Animal Health/Food and Agriculture Organization of the United Nations/H5N1 Evolution Working Group. Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir Viruses. 2012;6:1–5. DOIGoogle Scholar
  4. World Organisation for Animal Health. Latest animal disease events [cited 2022 May 3]. https://wahis.woah.org/#/home
  5. Chen  H, Li  Y, Li  Z, Shi  J, Shinya  K, Deng  G, et al. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol. 2006;80:5976–83. DOIPubMedGoogle Scholar
  6. Scotch  M, Mei  C, Makonnen  YJ, Pinto  J, Ali  A, Vegso  S, et al. Phylogeography of influenza A H5N1 clade 2.2.1.1 in Egypt. BMC Genomics. 2013;14:871. DOIPubMedGoogle Scholar
  7. Li  Y, Shi  J, Zhong  G, Deng  G, Tian  G, Ge  J, et al. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J Virol. 2010;84:8389–97. DOIPubMedGoogle Scholar
  8. Islam  MR, Haque  ME, Giasuddin  M, Chowdhury  EH, Samad  MA, Parvin  R, et al. New introduction of clade 2.3.2.1 avian influenza virus (H5N1) into Bangladesh. Transbound Emerg Dis. 2012;59:460–3. DOIPubMedGoogle Scholar
  9. Li  Y, Liu  L, Zhang  Y, Duan  Z, Tian  G, Zeng  X, et al. New avian influenza virus (H5N1) in wild birds, Qinghai, China. Emerg Infect Dis. 2011;17:265–7. DOIPubMedGoogle Scholar
  10. Kwon  JH, Lee  DH, Swayne  DE, Noh  JY, Yuk  SS, Erdene-Ochir  TO, et al. Highly pathogenic avian influenza A(H5N8) viruses reintroduced into South Korea by migratory waterfowl, 2014–2015. Emerg Infect Dis. 2016;22:507–10. DOIPubMedGoogle Scholar
  11. Shittu  I, Meseko  CA, Gado  DA, Olawuyi  AK, Chinyere  CN, Anefu  E, et al. Highly pathogenic avian influenza (H5N1) in Nigeria in 2015: evidence of widespread circulation of WA2 clade 2.3.2.1c. Arch Virol. 2017;162:841–7. DOIPubMedGoogle Scholar
  12. Bevins  SN, Dusek  RJ, White  CL, Gidlewski  T, Bodenstein  B, Mansfield  KG, et al. Widespread detection of highly pathogenic H5 influenza viruses in wild birds from the Pacific Flyway of the United States. Sci Rep. 2016;6:28980. DOIPubMedGoogle Scholar
  13. Dargatz  D, Beam  A, Wainwright  S, McCluskey  B. Case series of turkey farms from the H5N2 highly pathogenic avian influenza outbreak in the United States during 2015. Avian Dis. 2016;60:467–72. DOIPubMedGoogle Scholar
  14. Engelsma  M, Heutink  R, Harders  F, Germeraad  EA, Beerens  N. Multiple introductions of reassorted highly pathogenic avian influenza H5Nx viruses clade 2.3.4.4b causing outbreaks in wild birds and poultry in The Netherlands, 2020-2021. Microbiol Spectr. 2022;10:e0249921. DOIPubMedGoogle Scholar
  15. Cui  P, Zeng  X, Li  X, Li  Y, Shi  J, Zhao  C, et al. Genetic and biological characteristics of the globally circulating H5N8 avian influenza viruses and the protective efficacy offered by the poultry vaccine currently used in China. Sci China Life Sci. 2022;65:795–808. DOIPubMedGoogle Scholar
  16. Lewis  NS, Banyard  AC, Whittard  E, Karibayev  T, Al Kafagi  T, Chvala  I, et al. Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020. Emerg Microbes Infect. 2021;10:148–51. DOIPubMedGoogle Scholar
  17. Cui  P, Shi  J, Wang  C, Zhang  Y, Xing  X, Kong  H, et al. Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China. Emerg Microbes Infect. 2022;11:1693–704. DOIPubMedGoogle Scholar
  18. Bevins  SN, Shriner  SA, Cumbee  JC Jr, Dilione  KE, Douglass  KE, Ellis  JW, et al. Intercontinental movement of highly pathogenic avian influenza A(H5N1) clade 2.3.4.4 virus to the United States, 2021. Emerg Infect Dis. 2022;28:1006–11. DOIPubMedGoogle Scholar
  19. Miller  BJ. Why unprecedented bird flu outbreaks sweeping the world are concerning scientists. Nature. 2022;606:18–9. DOIPubMedGoogle Scholar
  20. Stokstad  E. Deadly flu spreads through North American birds. Science. 2022;376:441–2. DOIPubMedGoogle Scholar
  21. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2022, 11 November 2022 [cited 11 Nov. 2022]. https://www.who.int/publications/m/item/cumulative-number-of-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who-2003-2022-11-nov-2022
  22. Pyankova  OG, Susloparov  IM, Moiseeva  AA, Kolosova  NP, Onkhonova  GS, Danilenko  AV, et al. Isolation of clade 2.3.4.4b A(H5N8), a highly pathogenic avian influenza virus, from a worker during an outbreak on a poultry farm, Russia, December 2020. Euro Surveill. 2021;26:2100439. DOIPubMedGoogle Scholar
  23. Gu  W, Shi  J, Cui  P, Yan  C, Zhang  Y, Wang  C, et al. Novel H5N6 reassortants bearing the clade 2.3.4.4b HA gene of H5N8 virus have been detected in poultry and caused multiple human infections in China. Emerg Microbes Infect. 2022;11:1174–85. DOIPubMedGoogle Scholar
  24. Food and Agriculture Organization of the United Nations. Global avian influenza viruses with zoonotic potential situation update [cited 2022 Oct 15]. https://www.fao.org/animal-health/situation-updates/global-aiv-with-zoonotic-potential/en
  25. Lee  DH, Lee  HJ, Lee  YJ, Kang  HM, Jeong  OM, Kim  MC, et al. DNA barcoding techniques for avian influenza virus surveillance in migratory bird habitats. J Wildl Dis. 2010;46:649–54. DOIPubMedGoogle Scholar
  26. Katoh  K, Standley  DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30:772–80. DOIPubMedGoogle Scholar
  27. Tamura  K, Stecher  G, Kumar  S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol. 2021;38:3022–7. DOIPubMedGoogle Scholar
  28. Suchard  MA, Lemey  P, Baele  G, Ayres  DL, Drummond  AJ, Rambaut  A. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018;4:vey016. DOIPubMedGoogle Scholar
  29. Hill  V, Baele  G. Bayesian estimation of past population dynamics in BEAST 1.10 using the Skygrid coalescent model. Mol Biol Evol. 2019;36:2620–8. DOIPubMedGoogle Scholar
  30. Reed  L, Muench  H. A simple method of estimating fifty per cent endpoints. Am J Hyg (Lond). 1938;27:493–7.
  31. World Health Organization. Manual for the laboratory diagnosis and virological surveillance of influenza [cited 2022 Dec 15]. https://apps.who.int/iris/handle/10665/44518
  32. Zeng  X, Chen  X, Ma  S, Wu  J, Bao  H, Pan  S, et al. Protective efficacy of an H5/H7 trivalent inactivated vaccine produced from Re11, Re12, and H7-Re2 strains against challenge with different H5 and H7 viruses in chickens. J Integr Agric. 2020;19:2294–300. DOIGoogle Scholar
  33. Zeng  X, He  X, Meng  F, Ma  Q, Wang  Y, Bao  H, et al. Protective efficacy of an H5/H7 trivalent inactivated vaccine (H5-Re13, H5-Re14, and H7-Re4 strains) in chickens, ducks, and geese against newly detected H5N1, H5N6, H5N8, and H7N9 viruses. J Integr Agric. 2022;21:2086–94. DOIGoogle Scholar
  34. Yamada  S, Suzuki  Y, Suzuki  T, Le  MQ, Nidom  CA, Sakai-Tagawa  Y, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature. 2006;444:378–82. DOIPubMedGoogle Scholar
  35. Gao  Y, Zhang  Y, Shinya  K, Deng  G, Jiang  Y, Li  Z, et al. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog. 2009;5:e1000709. DOIPubMedGoogle Scholar
  36. Centers for Disease Control and Prevention. H5N1 genetic changes inventory: a tool for influenza surveillance and preparedness [cited 2022 Oct 20]. https://www.cdc.gov/flu/avianflu/h5n1-genetic-changes.htm
  37. Suttie  A, Deng  YM, Greenhill  AR, Dussart  P, Horwood  PF, Karlsson  EA. Inventory of molecular markers affecting biological characteristics of avian influenza A viruses. Virus Genes. 2019;55:739–68. DOIPubMedGoogle Scholar
  38. Kamal  RP, Kumar  A, Davis  CT, Tzeng  WP, Nguyen  T, Donis  RO, et al. Emergence of highly pathogenic avian influenza A(H5N1) virus PB1-F2 variants and their virulence in BALB/c mice. J Virol. 2015;89:5835–46. DOIPubMedGoogle Scholar
  39. Fan  S, Deng  G, Song  J, Tian  G, Suo  Y, Jiang  Y, et al. Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology. 2009;384:28–32. DOIPubMedGoogle Scholar
  40. Nao  N, Kajihara  M, Manzoor  R, Maruyama  J, Yoshida  R, Muramatsu  M, et al. A Single amino acid in the M1 protein responsible for the different pathogenic potentials of H5N1 highly pathogenic avian influenza virus strains. PLoS One. 2015;10:e0137989. DOIPubMedGoogle Scholar
  41. Jiao  P, Tian  G, Li  Y, Deng  G, Jiang  Y, Liu  C, et al. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol. 2008;82:1146–54. DOIPubMedGoogle Scholar
  42. Yin  X, Deng  G, Zeng  X, Cui  P, Hou  Y, Liu  Y, et al. Genetic and biological properties of H7N9 avian influenza viruses detected after application of the H7N9 poultry vaccine in China. PLoS Pathog. 2021;17:e1009561. DOIPubMedGoogle Scholar

Top

Figures
Table

Top

Cite This Article

DOI: 10.3201/eid2907.221149

Original Publication Date: June 08, 2023

1These authors contributed equally to this article.

Table of Contents – Volume 29, Number 7—July 2023

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Yanbing Li and Hualan Chen, Harbin Veterinary Research Institute, CAAS, 678 Haping Rd, Harbin 150069, China

Send To

10000 character(s) remaining.

Top

Page created: May 21, 2023
Page updated: June 20, 2023
Page reviewed: June 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external